ATE361931T1 - N1 modifizierte glycopeptide - Google Patents

N1 modifizierte glycopeptide

Info

Publication number
ATE361931T1
ATE361931T1 AT99909654T AT99909654T ATE361931T1 AT E361931 T1 ATE361931 T1 AT E361931T1 AT 99909654 T AT99909654 T AT 99909654T AT 99909654 T AT99909654 T AT 99909654T AT E361931 T1 ATE361931 T1 AT E361931T1
Authority
AT
Austria
Prior art keywords
modified glycopeptides
glycopeptides
modified
compounds
useful
Prior art date
Application number
AT99909654T
Other languages
German (de)
English (en)
Inventor
Richard Thompson
Stephen Wilkie
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE361931T1 publication Critical patent/ATE361931T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT99909654T 1998-05-01 1999-02-26 N1 modifizierte glycopeptide ATE361931T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8387998P 1998-05-01 1998-05-01

Publications (1)

Publication Number Publication Date
ATE361931T1 true ATE361931T1 (de) 2007-06-15

Family

ID=22181253

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99909654T ATE361931T1 (de) 1998-05-01 1999-02-26 N1 modifizierte glycopeptide

Country Status (10)

Country Link
US (3) US6670446B1 (enExample)
EP (1) EP1073447B1 (enExample)
JP (1) JP4307723B2 (enExample)
AT (1) ATE361931T1 (enExample)
AU (1) AU2881399A (enExample)
CA (1) CA2330619A1 (enExample)
DE (1) DE69936052T2 (enExample)
DK (1) DK1073447T3 (enExample)
ES (1) ES2283107T3 (enExample)
WO (1) WO1999056760A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1073447B1 (en) * 1998-05-01 2007-05-09 Eli Lilly And Company N1-modified glycopeptides
ES2201825T3 (es) 1998-12-23 2004-03-16 Theravance, Inc. Derivados del glicopeptidos y composiciones farmaceuticas que los contienen.
US6699836B2 (en) 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
WO2000059528A1 (en) * 1999-04-02 2000-10-12 The Trustees Of Princeton University Desleucyl glycopeptide antibiotics and methods of making same
WO2001058933A2 (en) * 2000-02-11 2001-08-16 Eli Lilly And Company Selective n-acylation of a82846 glycopeptide analogs
AR053347A1 (es) 2005-04-06 2007-05-02 Astrazeneca Ab Derivados de [1,3]tiazolo[4,5-d]pirimidin-2(3h)-ona 5,7-sustituidos
UA90707C2 (en) 2005-04-06 2010-05-25 Астразенека Аб Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
WO2007035938A2 (en) 2005-09-22 2007-03-29 Medivas, Llc BIS-(α-AMINO)-DIOL-DIESTER-CONTAINING POLY(ESTER AMIDE) AND POLY(ESTER URETHANE) COMPOSITIONS AND METHODS OF USE
WO2007038246A2 (en) 2005-09-22 2007-04-05 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
WO2009123713A1 (en) 2008-04-01 2009-10-08 Cornell University Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4643987A (en) 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
US4639433A (en) 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
EG18377A (en) * 1986-09-19 1993-04-30 Lilly Co Eli Process for preparing glycopeptide antibiotics
US5534420A (en) 1988-07-28 1996-07-09 Eli Lilly And Company Biotransformation of glycopeptide antibiotics
ZA909847B (en) * 1989-12-13 1992-08-26 Lilly Co Eli Glycopeptide derivatives
TW457248B (en) 1994-01-28 2001-10-01 Lilly Co Eli Glycopeptide antibiotic derivatives
US5952310A (en) * 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
EP1073447B1 (en) * 1998-05-01 2007-05-09 Eli Lilly And Company N1-modified glycopeptides

Also Published As

Publication number Publication date
JP4307723B2 (ja) 2009-08-05
ES2283107T3 (es) 2007-10-16
DE69936052D1 (de) 2007-06-21
DK1073447T3 (da) 2007-09-03
DE69936052T2 (de) 2008-01-17
EP1073447B1 (en) 2007-05-09
AU2881399A (en) 1999-11-23
US20050037950A1 (en) 2005-02-17
US6939947B2 (en) 2005-09-06
CA2330619A1 (en) 1999-11-11
US6670446B1 (en) 2003-12-30
WO1999056760A1 (en) 1999-11-11
US20060128609A1 (en) 2006-06-15
JP2002513764A (ja) 2002-05-14
EP1073447A4 (en) 2001-10-04
EP1073447A1 (en) 2001-02-07

Similar Documents

Publication Publication Date Title
EA200300050A1 (ru) Гликопептидфосфонатные производные
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
BR9808491A (pt) Compostos calcilìticos
FR07C0057I2 (fr) Derives de pleuromutiline utilises comme agents antimicrobiens
EA199900373A2 (ru) Фармацевтические композиции
BR0112452A (pt) Derivados de pleuromutilinas tendo atividade antibacteriana
ATE361931T1 (de) N1 modifizierte glycopeptide
SE9801494D0 (sv) Novel use
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
PT1194158E (pt) Uso da proteina uk 114 para inibir a rejeicao do transplante de orgaos
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
ATE459368T1 (de) Glycopeptid-antibiotika
RU96117132A (ru) Антибактериальное средство - родиола розовая
ATE478155T1 (de) Glycopeptidantibiotika
UY24326A1 (es) Nuevas piperidinas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties